Results for per os translation from Swedish to English

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Swedish

English

Info

Swedish

per os

English

oral administration

Last Update: 2011-02-10
Usage Frequency: 1
Quality:

Reference: Wikipedia

Swedish

os

English

os

Last Update: 2015-02-19
Usage Frequency: 7
Quality:

Reference: Wikipedia

Swedish

os triquetrum

English

triangular bone

Last Update: 2014-12-09
Usage Frequency: 5
Quality:

Reference: Wikipedia

Swedish

considera‑os:

English

do you deem these to be?

Last Update: 2017-04-06
Usage Frequency: 1
Quality:

Reference: Wikipedia

Swedish

- diarré orsakad av shigella dysenteriae typ 1 (per os:

English

2 x 400 mg/ d – 1 day) -diarrhoea caused by shigella dysenteriae type 1 (per os:

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Reference: Wikipedia

Swedish

läkemedlets biotillgänglighet hos kalv efter en engångsgiva per os är cirka 80%.

English

the bioavailability of the drug in the calf, following single oral administration, is about 80 %.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Reference: Wikipedia

Swedish

det är mindre troligt att denna påverkan uppträder vid inhalationsbehandling jämfört med när kortikosteroider ges per os.

English

these effects are much less likely to occur than with oral corticosteroids.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Reference: Wikipedia

Swedish

terminala halveringstiden är 11,7 timmar efter intravenös administrering och 30,84 timmar efter engångsgiva per os.

English

the terminal elimination half-life is 11.7 hours after iv administration and 30.84 hours after single oral administration.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Reference: Wikipedia

Swedish

i första hand skall voriconazol ges per os till dessa patienter, om inte en bedömning av risken i förhållande till fördelen för patienten motiverar användandet av intravenöst voriconazol.

English

oral voriconazole should be administered to these patients, unless an assessment of the risk benefit to the patient justifies the use of intravenous voriconazole.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Reference: Wikipedia

Swedish

i studier som förespråkar användning av ciprofloxacin per os vid akut exacerbation av kronisk sinuit och exacerbation av kronisk mediaotit var behandlingstiden 10 dagar, och resultaten har visat att denna duration är tillräcklig.

English

in studies supporting the use of oral ciprofloxacin in acute exacerbation of chronic sinusitis and exacerbation of chronic otitis media, the treatment duration was 10 days and efficacy results have shown that this duration was sufficient.

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Reference: Wikipedia

Swedish

figur 2: kaplan-meier kurva för os per behandlingsgrupp i lux-lung 8

English

figure 2: kaplan-meier curve for os by treatment group in lux lung 8

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Reference: Wikipedia

Swedish

om lumigan förtärs av misstag kan följande information vara till nytta: två veckors per os behandling 100 mg/ kg/ dag, hos mus resp. råtta visade ingen toxicitet.

English

if lumigan is accidentally ingested, the following information may be useful: in two-week oral rat and mouse studies, doses up to 100 mg/ kg/ day did not produce any toxicity.

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Reference: Wikipedia

Swedish

itrakonazol), makrolida antibiotika (klaritromycin, erytromycin per os, josamycin, telitromycin), hiv- proteashämmare (nelfinavir, ritonavir) och nefazodon (se avsnitt 4. 5 och 5. 2)

English

(ketoconazole, itraconazole), macrolide antibiotics (clarithromycin, erythromycin per os, josamycin, telithromycin), hiv protease inhibitors (nelfinavir, ritonavir) and nefazodone (see sections 4.5 and 5.2)

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Reference: Wikipedia

Get a better translation with
9,152,690,907 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK